Cargando…

Bortezomib sensitizes human glioblastoma stem cells to adoptive natural killer cell cytotoxicity

Detalles Bibliográficos
Autores principales:	Grossenbacher, Steven, Ames, Erik, Mac, Stephanie, Duan, Yuyou, Azeem, Syed, Canter, Robert, Murphy, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645253/ http://dx.doi.org/10.1186/2051-1426-3-S2-P17

Ejemplares similares

Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells
por: Luna, Jesus I., et al.
Publicado: (2019)

Enhanced natural killer cell targeting of cancer stem cells using Cetuximab
por: Grossenbacher, Steven K, et al.
Publicado: (2014)

Natural killer cell immunotherapy to target stem-like tumor cells
por: Grossenbacher, Steven K., et al.
Publicado: (2016)

Combination radioimmunotherapy with adoptive NK transfer targets cancer stem cells in canine models of bone and soft tissue sarcoma
por: Canter, Robert, et al.
Publicado: (2015)

Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival
por: Gras Navarro, Andrea, et al.
Publicado: (2019)

Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial
por: Canter, Robert J., et al.
Publicado: (2017)

Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells
por: Lundqvist, Andreas, et al.
Publicado: (2011)

Natural killer cells in antitumour adoptive cell immunotherapy
por: Laskowski, Tamara J., et al.
Publicado: (2022)

Treatment of relapsed extranodal natural killer/T-cell lymphoma with bortezomib plus fludarabine
por: Chen, Chen, et al.
Publicado: (2017)

A possible new pathway in natural killer cell activation also reveals the difficulty in determining human NK cell function in cancer
por: Canter, Robert J., et al.
Publicado: (2018)

Natural killer cell immunotherapy in glioblastoma
por: Hosseinalizadeh, Hamed, et al.
Publicado: (2022)

Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma
por: Kisseberth, William C., et al.
Publicado: (2021)

Magnetic fluid hyperthermia enhances cytotoxicity of bortezomib in sensitive and resistant cancer cell lines
por: Alvarez-Berríos, Merlis P, et al.
Publicado: (2013)

Advanced T and Natural Killer Cell Therapy for Glioblastoma
por: Yoon, Wan-Soo, et al.
Publicado: (2023)

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
por: Lupo, Kyle B., et al.
Publicado: (2019)

CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity
por: Bernareggi, Davide, et al.
Publicado: (2022)

Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma
por: Canter, Robert J, et al.
Publicado: (2014)

Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy
por: Gingrich, Alicia A., et al.
Publicado: (2019)

Natural Killer Cell-Based Immunotherapy against Glioblastoma
por: Morimoto, Takayuki, et al.
Publicado: (2023)

Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand
por: Oh, Se-Jeong, et al.
Publicado: (2017)

Adoptive Cell Therapies for Glioblastoma
por: Bielamowicz, Kevin, et al.
Publicado: (2013)

Natural Killer Cells: A Promising Kit in the Adoptive Cell Therapy Toolbox
por: Xiao, Jiani, et al.
Publicado: (2022)

Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells
por: Starheim, K K, et al.
Publicado: (2016)

Cystatin F Affects Natural Killer Cell Cytotoxicity
por: Perišić Nanut, Milica, et al.
Publicado: (2017)

The Lectin-like Receptor KLRE1 Inhibits Natural Killer Cell Cytotoxicity
por: Westgaard, Ingunn H., et al.
Publicado: (2003)

Novel non-canonical role of STAT1 in Natural Killer cell cytotoxicity
por: Putz, Eva Maria, et al.
Publicado: (2016)

Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells
por: Kim, Ji Sung, et al.
Publicado: (2015)

Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo
Publicado: (1985)

Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
por: Matosevic, Sandro
Publicado: (2018)

Inhibition of Natural Killer Cell Cytotoxicity by Cell Growth‐related Molecules
por: Tamura, Yasuaki, et al.
Publicado: (1996)

EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism
por: Modernelli, Alice, et al.
Publicado: (2015)

Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells
por: Villalba, Martin, et al.
Publicado: (2020)

Impact of polysialylated CD56 on natural killer cell cytotoxicity
por: Moebius, Jeannette M, et al.
Publicado: (2007)

Fas-mediated cytotoxicity by freshly isolated natural killer cells
Publicado: (1995)

Natural Killer Cell Mediated Cytotoxic Responses in the Tasmanian Devil
por: Brown, Gabriella K., et al.
Publicado: (2011)

Immunomodulatory Effect of Rhaphidophora korthalsii on Natural Killer Cell Cytotoxicity
por: Yeap, Swee Keong, et al.
Publicado: (2012)

Regulation of the Induction and Function of Cytotoxic T Lymphocytes by Natural Killer T Cell
por: Ito, Hiroyasu, et al.
Publicado: (2010)

Decreased Cytotoxicity of Peripheral and Peritoneal Natural Killer Cell in Endometriosis
por: Jeung, InCheul, et al.
Publicado: (2016)

Granule-Dependent Natural Killer Cell Cytotoxicity to Fungal Pathogens
por: Ogbomo, Henry, et al.
Publicado: (2017)

Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target
por: Gingrich, Alicia A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_19e1g7977dpt1u2j29j1el8s70